The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
暂无分享,去创建一个
R. Timman | V. Tjan-Heijnen | F. Erdkamp | M. Bos | J. Busschbach | J. Rademaker-Lakhai | A. K. M. Claessens | J. Bouma